- Home
- MED vs TKNO Comparison
MED vs TKNO Comparison
Compare MED & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- TKNO
- Stock Information
- Founded
- MED 1980
- TKNO 1996
- Country
- MED United States
- TKNO United States
- Employees
- MED N/A
- TKNO N/A
- Industry
- MED Packaged Foods
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MED Consumer Staples
- TKNO Health Care
- Exchange
- MED Nasdaq
- TKNO Nasdaq
- Market Cap
- MED 213.6M
- TKNO 244.7M
- IPO Year
- MED N/A
- TKNO 2021
- Fundamental
- Price
- MED $19.16
- TKNO $7.16
- Analyst Decision
- MED Hold
- TKNO Buy
- Analyst Count
- MED 1
- TKNO 2
- Target Price
- MED $17.00
- TKNO $5.00
- AVG Volume (30 Days)
- MED 180.6K
- TKNO 287.1K
- Earning Date
- MED 11-04-2024
- TKNO 11-07-2024
- Dividend Yield
- MED 34.45%
- TKNO N/A
- EPS Growth
- MED N/A
- TKNO N/A
- EPS
- MED 0.67
- TKNO N/A
- Revenue
- MED $674,475,000.00
- TKNO $36,347,000.00
- Revenue This Year
- MED N/A
- TKNO $3.23
- Revenue Next Year
- MED N/A
- TKNO $14.38
- P/E Ratio
- MED $28.78
- TKNO N/A
- Revenue Growth
- MED N/A
- TKNO N/A
- 52 Week Low
- MED $17.07
- TKNO $1.16
- 52 Week High
- MED $76.42
- TKNO $7.92
- Technical
- Relative Strength Index (RSI)
- MED 54.65
- TKNO 63.94
- Support Level
- MED $17.89
- TKNO $6.52
- Resistance Level
- MED $21.08
- TKNO $7.41
- Average True Range (ATR)
- MED 0.83
- TKNO 0.57
- MACD
- MED 0.21
- TKNO -0.04
- Stochastic Oscillator
- MED 50.13
- TKNO 57.30
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.